News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
232 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (232)
2 (101)
3 (1)
4 (13)
5 (26)
6 (344)
7 (346)
8 (264)
9 (107)
10 (31)
11 (18)
12 (255)
13 (267)
14 (212)
15 (206)
16 (111)
17 (4)
18 (5)
19 (157)
20 (226)
21 (187)
22 (190)
23 (79)
24 (1)
25 (3)
26 (175)
27 (201)
28 (178)
29 (232)
30 (88)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Novartis Nabs Merck Veteran to Helm BioMedical Institutes
Fiona H. Marshall has been tapped as Novartis Institutes for BioMedical Research president after Jay Bradner’s exit, while Tim Demuth will succeed Malte Peters for MorphoSys.
September 1, 2022
·
2 min read
·
Alex Keown
Business
Provention Nabs $125M in Preparation for Potential Diabetes Drug Launch
Provention Bio secured a $125 million loan from Hercules Capital that will support operations and the potential launch of the company’s type 1 diabetes treatment, teplizumab.
September 1, 2022
·
2 min read
·
Alex Keown
Sequana Medical Notice of 2022 Half Year Results and Business Update
Sequana Medical NV, a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, will announce its half year results ended 30 June 2022 on Thursday, 8 September 2022.
September 1, 2022
·
3 min read
Genetown
Evelo Biosciences to Participate in Morgan Stanley 20th Annual Global Health Care Conference
Evelo Biosciences, Inc. announced that the Company will participate in a fireside chat at the Morgan Stanley 20th Annual Health Care Conference on Tuesday, September 13th, 2022 at 12:20 p.m. ET.
September 1, 2022
·
4 min read
Genetown
Editas Medicine to Participate in Upcoming Investor Conferences in September 2022
Editas Medicine, Inc., a leading genome editing company, announced that management will participate in the following upcoming investor conferences.
September 1, 2022
·
1 min read
Pharm Country
Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina
Cambrex announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina.
September 1, 2022
·
2 min read
Medtronic ADAPT study results published in The Lancet Diabetes & Endocrinology show improved glycemic control and treatment satisfaction among those using MiniMed™ 780G system¹, compared to insulin injections
Medtronic plc, a global leader in healthcare technology, announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology.
September 1, 2022
·
6 min read
Genetown
Nuvalent to Participate in the Wells Fargo 2022 Healthcare Conference
Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022, at 2:35 p.m. ET in Boston.
September 1, 2022
·
1 min read
Biotech Beach
ChromaDex Announces Partnership with MyPharma2Go Corporation for Cross-Border Sales of Tru Niagen® and Tru Niagen® PRO into Brazil
Brazil is the first Latin American country to now welcome Tru Niagen®, with a strategy focused on reaching both consumers and Health Care Practitioners ChromaDex Corp. announced a partnership with MyPharma2Go to conduct cross-border sales of Tru Niagen® and Tru Niagen® PRO in Brazil, the first Latin American country to welcome the brand.
September 1, 2022
·
6 min read
Genetown
Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services for AC5® Advanced Wound System
Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical products, announced that it recently submitted an application to the Centers for Medicare & Medicaid Services for a unique HCPCS billing code for its AC5® Advanced Wound System.
September 1, 2022
·
4 min read
Previous
2 of 24
Next